E-mail

E-mail a Wiley Online Library Link

George R. Simon, Michael J. Schell, Mubeena Begum, Jongphil Kim, Alberto Chiappori, Eric Haura, Scott Antonia and Gerold Bepler Preliminary indication of survival benefit from ERCC1 and RRM1-tailored chemotherapy in patients with advanced nonsmall cell lung cancer: Evidence from an individual patient analysis Cancer 118

Version of Record online: 25 OCT 2011 | DOI: 10.1002/cncr.26522

The results from tailored first-line therapy using the molecular determinants excision repair cross complementing 1 and ribonucleotide reductase 1 indicate that personalized therapy improves survival over standard treatment-selection approaches.

Complete the form below and we will send an e-mail message containing a link to the selected article on your behalf

Required = Required Field

SEARCH